By Maureen Testoni December 22, 2020– We are coming to the end of a year like no other in our memories. A worldwide pandemic has caused the deaths of more than 300,000 of our fellow Americans. An economic recession has forced businesses to close and millions of hard-working people to lose their jobs and their income – and for many their health insurance. An election … [Read more...]
Keeping Diabetes in Check With 340B’s Help
November 25, 2020 – Chicago patient Hanan Tadros was struggling to manage her diabetes and her multiple other chronic conditions. That all started to change when she received diabetes education and medication therapy management services at UI Health in Chicago, resources available through the 340B drug pricing program. “They taught me how to take my insulin and they taught … [Read more...]
340B Helps Create a Brighter Future for Rural Health
November 19, 2020 – The headlines for rural hospitals and providers too often have been disheartening in the past decade. They include the fact that more than 130 rural hospitals have closed since 2010, according to the University of North Carolina Cecil G. Sheps Center for Health Services Research. But on National Rural Health Day, we take the time to celebrate the many … [Read more...]
This Anniversary, 340B Is As Important As Ever
November 16, 2020 – With all eyes focused on the 2020 elections earlier this month, it would have been understandable to have missed the anniversary of the 340B drug pricing program. Nov. 4 marked the observance of the date the law establishing 340B was enacted. Just as it did 28 years ago, when President George H.W. Bush signed the statute into law with little fanfare, the … [Read more...]
Faces of 340B: Making Chemotherapy Affordable
October 30, 2020 – Surrounded by her husband and daughter, Erika Aguero was crying because she had just found out the news no patient ever wants to hear. When she heard she had been diagnosed with breast cancer, she worried that she was going to die. Her immediate concern was not the lifesaving chemotherapy treatment itself but how she was going to be able to afford it. But she … [Read more...]
Faces of 340B: Breathing Easier
October 16, 2020 – Dan Hargrave was struggling to breathe, and he and his physicians initially were not sure why. He had asthma as a child, but his doctors were not confident this was the cause. Eventually, Dan was diagnosed with chronic obstructive pulmonary disease (COPD). He did not know it at the time, but the 340B drug pricing program would be a key element of how he would … [Read more...]
Drug Industry Report on 340B Attempts a Diversion from Unlawful Manufacturer Actions
October 14, 2020— A new report from the drug industry consultant Berkeley Research Group (BRG) takes aim at community-based pharmacies in the 340B drug pricing program. The report implies, without evidence, that for-profit pharmacy chains are making excessive profits on these arrangements. It ignores the fact that these partnerships provide critical funding for safety-net and … [Read more...]